Stereotaxis, Inc. (STXS)
After hours:
- GlobeNewswire
Stereotaxis to Present at Upcoming Investor Conferences
ST. LOUIS, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, Chairman and CEO, will represent Stereotaxis at two upcoming investor conferences. H.C. Wainwright 26th Annual Global Investment ConferenceMr. Fischel will present an overview of Stereotaxis business on Wednesday, September 11th, 2024, at 12:30 pm EST and will be available that same day for o
- GlobeNewswire
Stereotaxis Robotic Technology to be Featured during Heart Rhythm Society’s HRX Congress
ST. LOUIS, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that its technology will be prominently featured during the upcoming HRX digital health conference taking place September 5-7, 2024, in Atlanta, Georgia. HRX, an initiative pioneered by the Heart Rhythm Society (HRS), is focused on exploring digital technologies that advance the boundaries of innovation in cardi
- Zacks
Stereotaxis (STXS) Achieves CE Mark in Europe for GenesisX
Stereotaxis (STXS) gets a CE mark in Europe for its GenesisX robotic system. Following this, the company also submits a 501(k) application for FDA clearance.
